Condition: Plantar Fascitis · Gastrocnemius Tightness · Sponsor: Oslo University Hospital
This prospective clinical cohort study will follow 40 patients who recieve botulinum toxin A treatment for proximal medial gastrocnemius tightness with subsequent Chronic Plantar Fasciitis for two years. Three injections of botulinum toxin (75IU) will be administered with intervals of three months. Participants will be followed at baseline, 3 months, 6 months, 1 year and 2 years with Patient Related Outcome Measures (PROMS) and physical test (Ergotest and ankle dorsiflexion).
This description comes directly from the study's public registry record.
Elisabet Ellingsen Husebye, MD PhD · +47 91 50 27 70 · uxngng@ous-hf.no
Martin Riiser, MD Phd candidate · +47 91 50 27 70 · mriise@ous-hf.no
Always discuss trial participation with your own doctor first.
| Oslo University Hospital, Orthopedic Department Ullevål | Oslo, Oslo, Norway | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05218785